
TSE:SLF
This summary was created by AI, based on 12 opinions in the last 12 months.
Sun Life Financial Inc. (SLF) is seen as a generally solid investment by various experts, although the performance and outlook differ among analysts. Some highlight that SLF trades at a lower price-to-earnings ratio compared to Canadian banks and has demonstrated decent ROE figures, albeit with some recent challenges in its dental business in the U.S. Analysts suggest holding onto SLF, given its long-term growth potential, particularly in Asian markets, and its consistent dividend growth. Despite the positive aspects, there are concerns about current valuations, with some experts seeing it as not cheap relative to book value and growth expectations. Overall, the consensus indicates a bias towards maintaining existing positions while being cautious about new investments.
This had a negative US experience, which he sees turning around in the 2nd half. Just missed on the 2nd quarter. The Asian business is doing well being up 16%. He models them growing earnings at 7% compounded annually over the next couple of years. A little more expensive than Manulife (MFC-T), but coming much closer. Longer-term, this is fine. All things being equal, he would be buying it closer to $45.
Canadian Banks versus lifecos? He is a bigger fan of the lifecos. Manulife (MFC-T) and Sun Life (SLF-T) are going to get a big boost from rising interest rates. It is already starting to happen. The yield curve is steepening. Lifecos have been suffering and living with low interest rates for a long time. Both companies are also quite global. They have big presences in the US and in Asia. He sees a better earnings growth over the next few years.